Pay in 4 interest-free payments of $6.63 Learn more
Ships within 48 hours · Estimated delivery Aug 31 - Sep 5
Weight loss injections, particularly glucagon-like peptide-1 (GLP-1) receptor agonists such as semaglutide (Wegovy, Ozempic) and the dual glucose-dependent insulinotropic polypeptide (GIP)/GLP-1 receptor agonist tirzepatide (Zepbound, Mounjaro), have transformed obesity management in recent years
Grocery spending in GLP-1 households drops by 5.3%, with higher-income homes reducing spend by 8.2%
FDA responded by keeping these injectables on its drug-shortage list, which gives compounding pharmacies a narrow, but legal, window to prepare patient-specific versions until manufacturers catch up
Other peptides are prescribed legally as compounded medications through specialized clinics to support weight loss
Insider Tip: Even though GHK-Cu may protect the skin from UV damage, you should still always use a broad-spectrum sunscreen of at least SPF 30 when you go out
Antmen FM, Fedaioglu Z, Acar D, Sayar AK, Yavuz IE, Ada E, Karakose B, Rzayeva L, Demircan S, Kardouh F, Senay S, Kolgazi M, Suyen G, Oz-Arslan D (2024) Exploring Liraglutide in Lithium-Pilocarpine-Induced Temporal Lobe Epilepsy Model in Rats: Impact on Inflammation, Mitochondrial Function, and Behavior
